262 related articles for article (PubMed ID: 34028637)
1. The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.
Kanagal-Shamanna R
Curr Hematol Malig Rep; 2021 Aug; 16(4):336-344. PubMed ID: 34028637
[TBL] [Abstract][Full Text] [Related]
2. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
3. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
Gao J; Gong S; Chen YH
Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
[TBL] [Abstract][Full Text] [Related]
4. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
[TBL] [Abstract][Full Text] [Related]
5. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
7. Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia.
Galera P; Dulau-Florea A; Calvo KR
Int J Lab Hematol; 2019 May; 41 Suppl 1():131-141. PubMed ID: 31069978
[TBL] [Abstract][Full Text] [Related]
8. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications.
Liu YC; Geyer JT
Pathobiology; 2024; 91(1):30-44. PubMed ID: 37311434
[TBL] [Abstract][Full Text] [Related]
11. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
12. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
Reinig EF; Rubinstein JD; Patil AT; Schussman AL; Horner VL; Kanagal-Shamanna R; Churpek JE; Matson DR
Leukemia; 2023 Aug; 37(8):1589-1599. PubMed ID: 37393344
[TBL] [Abstract][Full Text] [Related]
13. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
14. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
15. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
16. Myeloid Neoplasms with Germline Predisposition.
Geyer JT
Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
[TBL] [Abstract][Full Text] [Related]
18. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
20. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
